Interleukin-10 polymorphisms in Spanish type 1 diabetes patients

Genes and Immunity

Volumn 5, Issue 4, 2004, Pages 306-309

  Urcelay, E ^a   Santiago, J L ^a   de la Calle, H ^b   Martinez A ^a   Figueredo, A ^a   Fernandez Arquero M ^a   de la Concha, E G ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

IL 10; Susceptibility; Type 1 diabetes

Indexed keywords

ADENINE; CYTOSINE; GUANINE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MICROSATELLITE DNA; THYMINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CAUCASIAN; CELLULAR IMMUNITY; CHILD; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE REPEAT; ONSET AGE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SPAIN; TH1 CELL; TH2 CELL;

DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; SPAIN;

EID: 3242683366     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364071     Document Type: Article

References (27)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
2. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
3. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
4. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000; 97: 1695-1700.
5. Sharif S, Arreaza GA, Zucker P, Delovitch TL. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann NY Acad Sci 2002; 958: 77-88.
6. Phillips JM, Parish NM, Drage M, Cooke A. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J Immunol 2001; 167: 6087-6091.
7. Pauza ME, Neal H, Hagenbaugh A, Cheroutre H, Lo D. T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes. Diabetes 1999; 48: 1948-1953.
8. Yang Z, Chen M, Wu R et al. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol 2002; 168: 6479-6485.
9. Goudy K, Song S, Wasserfall C et al. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci USA 2001; 98: 13913-13918.
10. Szelachowska M, Kretowski A, Kinalska I. Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-1. Horm Metab Res 1998; 30: 526-530.
11. Kallmann BA, Lampeter EF, Hanifi-Moghaddam P, Hawa M, Leslie RD, Kolb H. Cytokine secretion patterns in twins discordant for Type 1 diabetes. Diabetologia 1999; 42: 1080-1085.
12. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42: 444-445.
13. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 1996; 45: 82-83.
14. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-128.
15. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-1108.
16. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470.
17. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
18. Martinez Doncel A, Rubio A, Arroyo R et al. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients. J Neuroimmunol 2002; 131: 168-172.
19. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915-3922.
20. Ide A, Kawasaki E, Abiru N et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 2002; 63: 690-695.
21. Tegoshi H, Hasegawa G, Obayashi H et al. Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type 1 diabetes. Hum Immunol 2002; 63: 121-128.
22. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun 2003; 4: 117-121.
23. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
24. Morahan G, Morel L. Genetics of autoimmune diseases in humans and in animal models. Curr Opin Immunol 2002; 14: 803-811.
25. Wanstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001; 2: 802-809.
26. Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-9984.
27. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus- host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-3946.